Oncology Information Systems Market (2026 - 2033)

Oncology Information Systems Market Summary

The global oncology information systems market size was valued at USD 3.2 billion in 2025 and is projected to grow from USD 3.4 billion in 2026 to USD 6.0 billion by 2033, growing at a CAGR of 8.3% from 2026 to 2033. The North America oncology information systems market held the largest share of 39.7% of the global market in 2025. The increasing burden of cancer cases and the growing need for precision oncology drive the adoption of oncology information systems (OIS).

In addition, the shift toward artificial intelligence (AI)-driven treatment planning and real-time patient monitoring is transforming oncological workflows by enhancing accuracy and efficiency.

Market Dynamics

The oncology information systems market is gaining momentum as healthcare providers increasingly adopt digital solutions to improve cancer care management, treatment planning, and clinical workflow efficiency. Oncology information systems offer a comprehensive range of functionalities, including patient data management, radiation treatment planning, chemotherapy management, clinical decision support, scheduling, and integration with electronic health records. The growing global burden of cancer, increasing demand for personalized and precision oncology, and the need to streamline complex oncology workflows are driving adoption across healthcare facilities.

Market Concentration & Characteristics

The chart below illustrates the relationship between market concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, impact of regulations, level of partnerships & collaborations activities, degree of innovation, and regional expansion. For instance, the oncology information system industry is slightly fragmented, with many product & service providers entering the market. The degree of innovation, the level of partnerships & collaboration activities, and the impact of regulations on the industry are high. However, the regional expansion observes moderate growth.

The degree of innovation in the industry is high. The market is experiencing significant innovation as numerous players introduce new AI-integrated products to simplify hospital workflows and enhance patient care. For instance, in October 2024, GE Healthcare launched CareIntellect. This AI-powered cloud-based oncology application allows healthcare providers to assess disease progression and identify deviations from the treatment plan, helping them make informed decisions regarding future treatment regimes. This application also helps assess clinical trial eligibility and tracks adherence to treatment protocols. 

The level of partnerships & collaboration activities by key players in the industry is high to increase their capabilities, expand product portfolios, and improve competencies. For instance, in June 2022, Accuray Incorporated and Limbus AI Inc. entered a strategic partnership to amalgamate Limbus’ AI-powered auto-contouring algorithms with Accuray’s adaptive radiotherapy capabilities. 

"Accuray is focused on improving the care of patients undergoing radiation therapy. Providing practical adaptive solutions for clinics of any size, in any location, is one approach, and the software offered by Limbus AI will play a big role in making this goal a reality. The partnership with Limbus represents another step forward for Accuray in the development of innovative artificial intelligence (AI)-driven solutions that meet the needs of providers and enable them to deliver personalized patient care, such as with our Synchrony AI-driven real-time target tracking with dynamic delivery technology, on both the Radixact and CyberKnife Systems."

- Joshua H. Levine, chief executive officer of Accuray.

The impact of regulations on the market is high. Oncology information systems are considered under healthcare information systems. The regulations for Healthcare Information Systems in the U.S. are primarily focused on protecting Personal Health Information (PHI) and ensuring secure data exchange. Moreover, in Europe, the European Medicines Agency (EMA) oversees the regulation of medical devices and software under the Medical Device Regulation (MDR). Regulations such as the Health Insurance Portability and Accountability Act (HIPAA) in the U.S. and the General Data Protection Regulation (GDPR) in Europe impose strict requirements on data privacy and security for software that handles sensitive patient information. 

The level of regional expansion in the industry is moderate. Increasing demand for oncology information systems in developing countries, owing to the robust investments in healthcare IT. For instance, in February 2022, Elekta announced the establishment of an office in Manila, Philippines, to expand its business presence and product offerings in Southeast Asian markets. Through this business establishment, Elekta will address the gap in the Philippines’ radiation therapy market and patient accessibility.

Analyst Perspective

The oncology information systems market is benefiting from the rising global cancer burden, increasing adoption of digital healthcare technologies, and growing demand for integrated oncology care management solutions. The expansion of radiation therapy centers, precision oncology programs, and multidisciplinary cancer treatment approaches is driving the need for advanced platforms that streamline clinical workflows, patient data management, treatment planning, and outcomes monitoring. Advances in cloud computing, artificial intelligence, interoperability, and analytics capabilities are further enhancing the value proposition of OIS solutions. The key competitive advantage will lie with vendors that provide comprehensive, interoperable platforms capable of integrating electronic health records, treatment planning systems, imaging data, and clinical decision support tools. By enabling seamless coordination across the oncology care continuum and supporting data-driven treatment decisions, OIS providers can improve operational efficiency, enhance patient outcomes, and strengthen their market position in an increasingly digital oncology ecosystem.

Technological Advancements

The integration of artificial intelligence (AI) and machine learning (ML) is transforming OIS functionality. AI-enabled OIS platforms process data from electronic health records, genomic profiles, and medical imaging to automate patient management, predict treatment outcomes, and improve tumor detection. For instance, in July 2025, the FDA granted Breakthrough Device Designation to Artera's ArteraAI Prostate software, the first AI-powered risk stratification tool for localized prostate cancer. 

“This designation is a powerful validation of our software's potential to transform how we treat cancer. We’re proud that the FDA has recognized our innovative technology platform, and we’re excited to be advancing the frontier of oncology by delivering differentiated and clinically relevant tools that can help save more lives.” - Andre Esteva, CEO of Artera. 

Products & Services Insights

Based on products & services, the solutions segment dominated the market with revenue share of 73.9% in 2025 and is expected to grow at the fastest CAGR during the forecast period. The software solutions used in OIS help maintain patient records, predict treatment results, and plan treatment regimes for cancer patients. These software solutions facilitate the exchange of patient information across healthcare organizations to create a bridge between practitioners and radiology centers, which helps in improving the safety and efficiency of cancer treatment. In addition, these software solutions also help physicians and surgeons select a suitable treatment, which, in turn, helps improve the survival rates of cancer patients. For instance, in December 2024, Varian, a Siemens Healthineers company, received 510(k) clearance from the U.S. FDA to sell its RapidArc Dynamic treatment planning solution. 

“RapidArc Dynamic is the latest example of Varian’s sustained investment in innovation, and ushers in a radical transformation in radiotherapy planning and delivery designed to bring flexibility to care teams using arc therapy.”

-said Sasa Mutic, PhD, President, Radiation Oncology Solutions for Varian. 

Moreover, the professional services segment is expected to grow significantly over the forecast period, as these services are increasingly outsourced. As hospitals and clinics lack in-house resources and skills required for deployment of OIS software, these services are outsourced. Outsourcing can be a short-term project or a long-term contract. 

Application Insights

Based on application, the medical oncology segment accounted for the largest revenue share of 61.7% in 2025. Medical oncology is a modality of cancer treatment that involves the use of immunotherapy, chemotherapy, hormonal therapy, and targeted therapy. This modality offers a comprehensive and efficient approach to treating cancer. Furthermore, the increasing prevalence of cancer is expected to drive market growth. Increasing usage of the above therapies for effective treatment of cancer is expected to drive market growth. 

The surgical oncology and radiation oncology segments are also expected to witness significant growth during the forecast years. Cancer care has evolved rapidly over the decades. Surgery is no longer the treatment for most solid malignancies, but the combination of surgery and multi-modal therapies, mostly focused on radiotherapy, targeted molecular therapies, and chemotherapy, is the preferred treatment. As a result, surgeons must communicate with different specialists for treatment and have to work with a multidisciplinary team. Thus, increasing complexity in surgical treatments for solid malignancies is expected to drive the growth of the surgical oncology OIS market. 

End Use Insights

Based on end use, the hospitals & diagnostic imaging centers segment held the largest revenue share of 47.6% in 2025. Hospitals increasingly adopt OIS to streamline workflows, integrate multidisciplinary data, and enhance treatment planning. By connecting oncologists, radiologists, and pathologists, OIS enables comprehensive patient data management, reducing errors and improving efficiency. In addition, the integration with EHRs minimizes redundant testing and optimizes resource utilization. As hospitals expand radiation oncology services and seek cost-effective cancer care solutions, the demand for OIS is expected to grow, driving market expansion and innovation in oncology treatment.

The ablation care centers and cancer care centers segment is anticipated to grow at the fastest CAGR from 2026 to 2033, driven by the rising adoption of minimally invasive cancer therapies. These centers utilize OIS to integrate real-time imaging, ablation devices, and patient data for precise tumor targeting. These centers utilize OIS to integrate real-time imaging, ablation devices, and patient data for precise tumor targeting. For instance, RaySearch Laboratories’ RayCare OIS supports liver ablation workflows by automating treatment planning and tracking procedural outcomes, enhancing efficiency in clinics. 

Regional Insights

North America oncology information systems market held the largest revenue share of 39.7% in 2025. The use of oncology information systems for cancer patients is on the rise, driven by the need for efficient, precise, and advanced cancer treatment and care methods. In addition, the availability of advanced healthcare infrastructure and cancer research institutions, substantial healthcare spending, high patient disposable incomes, and a well-established reimbursement framework all contribute to the increased implementation of oncology information systems.

U.S. Oncology Information Systems Market Trends

The oncology information systems market in the U.S. held the largest share in the North America region in 2025. The growing prevalence of cancer among various demographics and the rising demand for advanced innovative oncology information systems are some of the driving factors for the U.S. For instance, according to an article published in the PubMed Journal in January 2024, 2 million new cancer cases were expected to be diagnosed in the U.S. in 2024, with 611,720 cancer deaths. Moreover, an increase in investments in cancer research by companies is driving industry growth. A wide range of novel technologies are being developed, which have the potential to drastically change the treatment regime. 

Europe Oncology Information Systems Market Trends

The oncology information systems market in Europe is anticipated to grow significantly over the forecast period. The primary factor driving this demand is the rising prevalence of cancer in European countries. In addition, a shift from conventional cancer care to advanced treatment solutions is contributing to the increased demand for oncology information systems. For instance, in October 2025, Leo Cancer Care introduced Grace, its upright photon therapy system compatible with RaySearch Laboratories' RayCare oncology information system. Moreover, EU policymakers are promoting various digital health programs, which are expected to boost market growth during the forecast period. For instance, the European Federation for Cancer Images (EUCAIM) project is a significant initiative funded by the Digital EU Program (DIGITAL) as part of Europe’s Beating Cancer Plan. 

The UK oncology information systems marketis expected to grow significantly over the forecast period. An increasing number of initiatives, including the development of integrated care systems for digital health and eHealth, is expected to drive the UK market. For instance, the NHS in England has allocated USD 22.8 million to 64 NHS trusts. This funding is aimed at deploying artificial intelligence tools specifically designed to expedite the diagnostic process for lung cancer. 

The oncology information systems market in Germany dominated Europe with the largest share in 2025. Increase in the significance of IT due to efficient utilization of resources, improvement in workflow & delivery of services, and enhanced patient centricity are significant factors contributing to the growing adoption of these technologies in hospitals. Furthermore, the initiatives taken by the market players are further propelling market growth. For instance, in 2024, the Partex Group, through its companies Innoplexus AG and Amrit AG, presented results from a pilot project at the German Cancer Congress 2024 in Berlin. This project was conducted in collaboration with the German Cancer Society’s Working Group for Internal Oncology (AIO) and aimed to explore the feasibility and effectiveness of modern AI-supported technologies in oncology.   

Asia Pacific Oncology Information Systems Market Trends

The oncology information systems market in the Asia Pacific is expected to witness the fastest growth over the forecast period. The region experiences high demand for oncology information systems due to the rising prevalence of cancer and an increase in government spending on healthcare. Furthermore, this region’s market growth can also be attributed to R&D investments in artificial intelligence, producing technologically advanced healthcare solutions. Moreover, developing healthcare infrastructure in Asia Pacific countries, such as Indonesia, China, & India, is expected to propel market growth. 

China oncology information systems market held the largest share in 2025. The country’s growing geriatric population and associated increase in disease burden, along with improving healthcare facilities & growing healthcare expenditure, are anticipated to propel the market. The Strengthening Information Society Research Capacity Alliance program states that the State Council requires hospitals to invest at least 5% of their annual revenue in healthcare information systems that include OIS. Thus, such systems are being widely used in large hospitals in China and are being adopted in other healthcare setups. 

The oncology information systems market in Indiais expected to grow significantly over the forecast period. The Indian market is driven by the growing geriatric population, increasing burden of chronic diseases, and government initiatives supporting the country’s eHealth scenario. In addition, efforts to improve healthcare infrastructure are likely to boost the market. The Government of India has undertaken various initiatives to support digital health. Significant investments have been made to develop healthcare IT infrastructure. 

Latin America Oncology Information Systems Market Trends

The oncology information systems market in Latin America is anticipated to grow significantly. Countries’ steps into digital health have taken various forms, ranging from adopting telemedicine solutions to implementing more extensive standards, such as the government’s approach to applying SNOMED to its medical data systems to accomplish future integration. The advent of 5G technology has opened new avenues for telemedicine, particularly in the field of oncology. 

Middle East & Africa Oncology Information Systems Market Trends

The oncology information systems market in MEA is expected to grow significantly over the forecast period. Market growth in this region can be attributed to the steady development of healthcare facilities in emerging economies and an increase in healthcare expenditure. Some of the key countries in the region, such as Saudi Arabia and the UAE, have exhibited significant growth & major changes in healthcare facilities. Furthermore, the growing demand for healthcare IT services, along with the increasing use of blockchain technology in oncology information systems, is anticipated to drive market growth. 

Key Oncology Information Systems Company Insights

The market is highly fragmented, with many small and large players operating in this space. This leads to intense competition between smaller players to sustain their position. Strategies such as new product launches and partnerships are playing a key role in propelling the market growth.

Key Oncology Information Systems Companies:

The following key companies have been profiled for this study on the  oncology information systems market.

• Accuray Incorporated

• Elekta

• BrainLab

• Prowess, Inc.

• DOSIsoft SA

• FLATIRON HEALTH

• RaySearch Laboratories

• Oracle

• Koninklijke Philips N.V.

• Varian Medical Systems, Inc. (Siemens Healthineers).

Competitive Benchmarking

Recent Developments

• In February 2026, Flatiron Health launched AI-powered Panoramic prostate cancer datasets covering nearly 400,000 patients across the US, UK, and Germany. Built on a unified common data model, these datasets aggregate structured and unstructured EHR data, including PSMA-PET scans, PSA values, 19 HRR genes, recurrence, and progression details.

“Flatiron is not just adding more data; we are building the singular destination for global oncology intelligence. By unifying fragmented global records into a single evidence platform, we are fundamentally changing how our customers develop therapies and-most importantly-when patients can access them.”

- Kate Estep, Chief Product Officer at Flatiron Health.

• In September 2025, RaySearch Laboratories released RayIntelligence v2025, an update to its cloud-based oncology analytics platform. Key enhancements include customizable dashboards and charts for plan quality trends, machine utilization, protocol adherence, and outcome analysis.

• In June 2025, RaySearch Laboratories released RayCare v2025, its next-generation oncology information system. Key enhancements include Microsoft Word integration for patient documentation within charts, DICOM Modality Worklist for automated imaging workflows, HL7 inbound scheduling from hospital systems, and automatic AJCC 8th edition cancer staging.

• In May 2025, GE HealthCare expanded its radiation oncology portfolio at ESTRO 2025 with AI-enabled MR Contour DL for organ-at-risk segmentation from MR images. It plans to integrate Spectronic Medical’s MRI Planner for MR-only radiotherapy workflows, thereby enhancing treatment planning precision in the head and neck and pelvic regions.

• In August 2024, the Connecticut Proton Therapy Center integrated RaySearch Laboratories AB’s oncology information system, RayCare, and the IBA ProteusONE compact proton therapy system as its treatment platform.

“We are happy to welcome yet another RayCare customer. For our installed base of RayStation customers, the selection of RayCare as an oncology information system will enhance efficiency and user experience, both in the treatment planning process and treatment delivery.”

-Johan Löf, founder and CEO, RaySearch

• In July 2024, MIT and ETH Zurich developed an AI model to detect stages of Ductal Carcinoma in Situ (DCIS) from breast tissue images, helping to accelerate diagnosis and reduce complex testing. These advancements are making OIS essential for delivering data-driven, personalized cancer care and improving patient outcomes.

• In January 2024, RaySearch Laboratories launched RayStation 2024A, enhancing clinical workflows in treatment planning. RayStation 2024A also integrates with the oncology analytics system RayIntelligence.

Oncology Information Systems Market Report Scope

Global Oncology Information Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global oncology information systems market report based on products & services, application, end use, and region:

• Products & Services Outlook (Revenue, USD Million, 2021 - 2033)

  • Solutions

    • Patient Information Systems

    • Treatment Planning Systems

  • Professional Services

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Medical Oncology

  • Radiation Oncology

  • Surgical Oncology

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals and Diagnostic Imaging Centers

  • Ablation Care Centers and Cancer Care Centers

  • Government Institutions

  • Research Facilities

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

Segment Definition

Estimation Model

Model Details

This research methodology outlines the process for estimating the size of the global oncology information system (market for the period from 2021 to 2033. The study covers key solution segments, including patient information management, treatment planning systems integration, radiation oncology workflow management, medical oncology information systems, clinical decision support, analytics and reporting solutions, and cloud-based oncology platforms across major geographic regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The objective is to develop a robust and defensible market estimate through a combination of bottom-up and top-down approaches supported by primary industry validation.

A triangulated market sizing approach was used, combining:

• Bottom-Up Analysis from oncology treatment facility counts, oncology information system adoption rates, and average software spending per facility.

• Top-Down Checks using cancer incidence rates, oncology treatment volumes, healthcare IT expenditure, digital health adoption trends, and industry publications.

• Primary Research with hospital administrators, oncology centers, radiation oncologists, medical oncologists, healthcare IT managers, software vendors, system integrators, and industry consultants.

Step-By-Step Market Estimation Process

• Vendor Revenue Extrapolation Model

  • This model estimates market size using revenues generated by leading oncology information system providers.

    • Step 1: Major OIS vendors and solution providers were identified through industry databases, company reports, healthcare IT directories, and primary interviews.

    • Step 2: Oncology-specific revenues were estimated using annual reports, segment disclosures, investor presentations, and expert consultations.

    • Step 3: Vendor revenues were adjusted to account for private companies, regional vendors, channel partners, and unreported market participants.

    • Step 4: Country-level and regional revenues were estimated based on vendor geographic presence and customer distribution.

    • Step 5: Global market size was derived by aggregating adjusted vendor revenues.

    • Step 6: Annual adjustments were applied to reflect new software deployments, subscription model transitions, product upgrades, and market expansion activities.

• Healthcare Facility-Based OIS Adoption Model

  • This model calculates market size by estimating the number of healthcare facilities utilizing oncology information systems and their annual spending on software, implementation, and support services.

    • Step 1: Country-level data on hospitals, cancer centers, radiation therapy facilities, and specialty oncology clinics for 2021-2025 was collected from healthcare databases, cancer registries, government publications, and industry associations.

    • Step 2: An oncology information system adoption rate was applied, estimating the percentage of eligible facilities utilizing OIS solutions. Adoption rates were derived from primary interviews, healthcare IT surveys, vendor disclosures, and industry reports.

    • Step 3: Average annual spending per facility was estimated using software licensing data, subscription fees, implementation contracts, maintenance agreements, and vendor interviews.

    • Step 4: Market size was calculated by multiplying facility count × OIS adoption rate × average annual spending per facility.

    • Step 5: Calculations were performed at the country level and subsequently aggregated to regional and global levels.

    • Step 6: Historical and forecast growth rates were incorporated based on healthcare digitization initiatives, oncology infrastructure expansion, and cloud software adoption trends.

• Cancer Incidence and Treatment Volume Model

  • This model estimates market size based on oncology patient volumes and associated demand for digital oncology management solutions.

    • Step 1: Cancer incidence and prevalence data were collected from cancer registries, healthcare agencies, oncology associations, and published literature.

    • Step 2: Oncology treatment volumes were categorized into radiation therapy, chemotherapy, immunotherapy, targeted therapy, and multidisciplinary cancer care programs.

    • Step 3: OIS utilization intensity was estimated based on treatment complexity, patient management requirements, and digital workflow adoption.

    • Step 4: Revenue contribution was calculated by estimating software spending associated with oncology patient management and treatment workflows.

    • Step 5: Country-level revenues were aggregated to determine regional and global market sizes.

    • Step 6: Forecast assumptions incorporated rising cancer incidence, precision oncology adoption, interoperability requirements, and healthcare digital transformation initiatives.

Geographic Demand Potential Index (GDPI) Validation Model

In addition to the core triangulation models, a Geographic Demand Potential Index (GDPI) model was developed to benchmark oncology information system demand across countries and regions globally. This model applied four macroeconomic and industry-specific indicators:

• Cancer Incidence and Oncology Patient Population

• Healthcare IT Expenditure and Digital Health Adoption

• Oncology Infrastructure and Treatment Capacity

• Government Healthcare Modernization and Reimbursement Support

Each country's GDPI score was calculated and normalized to estimate its relative share of global oncology information system demand. The resulting scores were used as a validation framework for the market estimates generated through the core models, ensuring alignment with actual market concentration, healthcare technology adoption patterns, and regional growth dynamics.

Final Market Triangulation

The final global oncology information systems market size was derived through triangulation of:

• Healthcare Facility-Based OIS Adoption Model

• Vendor Revenue Extrapolation Model

• Cancer Incidence and Treatment Volume Model

• Geographic Demand Potential Index (GDPI) Validation Model

The weighted average of these models, validated through primary interviews and secondary industry sources, was used to generate the final historical estimates (2021-2025) and forecast projections (2026-2033) for the global oncology information systems market.

Delivered Customizations

This report has been delivered with the following In-depth customizations